Literature DB >> 17317686

Stimulation of hepatocyte growth factor production by heparin-derived oligosaccharides.

Ryoichi Sakiyama1, Kazuhiro Fukuta, Kunio Matsumoto, Masumi Furukawa, Yoshihiro Takahashi, Toshikazu Nakamura.   

Abstract

We previously reported that heparin post-transcriptionally stimulates the production of hepatocyte growth factor (HGF). In this study, we addressed the size-dependency of heparin fragments on the HGF-inducing activity aiming to obtain fragments without antiblood coagulant activity. Heparin fragments, produced by digestion with heparinase, were size-fractionated and tested for HGF-inducing activity in cultured human fibroblasts. The HGF-inducing activity deceased with the reduction in oligosaccharide size. Decasaccharides exerted an activity comparable with undigested heparin, while smaller oligosaccharides showed lesser activities. The anticoagulant activity of heparin fragments also decreased with size and anticoagulant activity of decasaccharides was <13% that of undigested heparin. Further fractionation of decasaccharides by anion-exchange chromatography revealed that most of the decasaccharides had HGF-inducing activity and the extent of sulfation was roughly related to the activity. The lack of N-sulfation in heparin markedly reduced HGF-inducing activity, whereas 2-O-desulfation or 6-O-desulation had a lesser influence. Moreover, an N-sulfated disaccharide showed significant HGF-inducing activity, suggesting the involvement of N-sulfation in HGF-inducing activity. Because of the much reduced anticoagulant activity, potential applications of heparin-derived oligosaccharides such as decasaccharides is considerable as a therapeutic agent for many diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17317686     DOI: 10.1093/jb/mvm067

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  10 in total

1.  Heparin protects against septic mortality via apoE-antagonism.

Authors:  Kelley I Chuang; Briana Leung; Nancy Hsu; Hobart W Harris
Journal:  Am J Surg       Date:  2011-07-08       Impact factor: 2.565

2.  Structure of pleiotrophin- and hepatocyte growth factor-binding sulfated hexasaccharide determined by biochemical and computational approaches.

Authors:  Fuchuan Li; Chilkunda D Nandini; Tomohide Hattori; Xingfeng Bao; Daisuke Murayama; Toshikazu Nakamura; Nobuhiro Fukushima; Kazuyuki Sugahara
Journal:  J Biol Chem       Date:  2010-06-28       Impact factor: 5.157

3.  Daily administration of low molecular weight heparin increases Hepatocyte Growth Factor serum levels in gynaecological patients: pharmacokinetic parameters and clinical implications.

Authors:  Anna Surbone; Luca Fuso; Roberto Passera; Annamaria Ferrero; Cristiana Marchese; Cosimo Martino; Annalisa Luchin; Maria Flavia Di Renzo; Paolo Zola
Journal:  BMC Res Notes       Date:  2012-09-23

4.  Three-dimensional coculture provides an improved in vitro model for papillary renal cell carcinoma.

Authors:  Kylee A Rosette; Stephen M Lander; Calvin VanOpstall; Brendan D Looyenga
Journal:  Am J Physiol Renal Physiol       Date:  2021-05-24

5.  Identification of core active disaccharides in heparin for HGF-inducing activity.

Authors:  Takashi Kato; Ryoichi Sakiyama; Kiyomasa Oka; Toshikazu Nakamura
Journal:  J Pharmacol Pharmacother       Date:  2015 Apr-Jun

6.  Absence of apolipoprotein E protects mice from cerebral malaria.

Authors:  Fikregabrail Aberra Kassa; Kristin Van Den Ham; Anthony Rainone; Sylvie Fournier; Eric Boilard; Martin Olivier
Journal:  Sci Rep       Date:  2016-09-20       Impact factor: 4.379

7.  Low-Molecular-Weight Heparin Enhanced Therapeutic Effects of Human Adipose-Derived Stem Cell Administration in a Mouse Model of Lupus Nephritis.

Authors:  Shogo Matsuda; Takuya Kotani; Takashi Saito; Takayasu Suzuka; Tatsuhiko Mori; Tohru Takeuchi
Journal:  Front Immunol       Date:  2022-01-13       Impact factor: 7.561

8.  Therapeutic effects of adipose-derived mesenchymal stem/stromal cells with enhanced migration ability and hepatocyte growth factor secretion by low-molecular-weight heparin treatment in bleomycin-induced mouse models of systemic sclerosis.

Authors:  Takayasu Suzuka; Takuya Kotani; Takashi Saito; Shogo Matsuda; Takako Sato; Tohru Takeuchi
Journal:  Arthritis Res Ther       Date:  2022-10-07       Impact factor: 5.606

Review 9.  Polyanionic drugs and viral oncogenesis: a novel approach to control infection, tumor-associated inflammation and angiogenesis.

Authors:  Chiara Urbinati; Paola Chiodelli; Marco Rusnati
Journal:  Molecules       Date:  2008-11-06       Impact factor: 4.411

10.  Antifibrotic therapy by sustained release of low molecular weight heparin from poly(lactic-co-glycolic acid) microparticles on bleomycin-induced pulmonary fibrosis in mice.

Authors:  Takashi Saito; Takuya Kotani; Koichi Suzuki
Journal:  Sci Rep       Date:  2020-11-04       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.